ABCG2 and non-small cell lung carcinoma: Interestingly, silencing ABCG2 in miR-128-3p-overexpressing NSCLC cells enhanced theintake of gemcitabine and paclitaxel and cellular apoptosis induced by the two drugs but did not influence cisplatin uptake or cisplatin-induced apoptosis (Fig. 2j and Supplementary Fig. 3g–i), suggesting that various drug transporter proteins might together contribute to miR-128-3p-induced chemoresistance in NSCLC cells.